Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
J Med Assoc Thai 99(Suppl 7):S133-137 Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C (2017) Inhaled magnesium sulfate in the treatment of acute asthma
Taking the diabetic medication, Metformin, is associated with a higher risk for Vitamin B12 deficiency
Some people may also experience nausea and vomiting, so it is best to take with food
GLP-2: glucagon-like peptide-2